JPRN-UMIN000030854已完成未知
Phase I study of personalized peptide vaccination with transdermal adjuvant for cancer patients - Phase I study of personalized peptide vaccination with transdermal adjuvant
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patient meets the followings: 1) under or have a plan of treatment with molecular tagetting or chemotherapy during this study 2) other severe diseases 3) severe allagic dideases 4) sensitive to adhesive plaster 5) woman with plegnancy or under milk feeding, man who is not accept contaception 6) doctor consider who is not appropriate for this study
研究者
相似试验
已完成
1 期
A phase I trial of personalized peptide vaccination using long and short peptides in patients with metastatic cancer resistant to standard treatmentsMetastatic cancer resistant to standard treatmentsJPRN-UMIN000013029Kurume University Cancer Vaccine Center10
已完成
2 期
Phase II study of personalized peptide vaccination in bladder cancer patients progressing after first-line platinum-containing regimeBladder cancerJPRN-UMIN000003157Kurume University Research Center for Innovative Cancer Therapy, Clinical Research Division80
已完成
2 期
A phase II trial of personalized peptide vaccination for nine kinds of cancersProstate cancer, Urothelial cancer, Breast cancer, Lung cancer, Ovarian cancer, Gastric cancer, Colon cancer, Liver cancer, Pancreatic cancerJPRN-UMIN000029789Kurume University900
已完成
2 期
A phase II trial of personalized peptide vaccination for rare cancer or primary unknown cancer patientsJPRN-UMIN000014855Kurume University Cancer Vaccine Center200
已完成
2 期
A phase II trial of personalized peptide vaccination for several cancer patients with slight bone marrow suppressioCancer patients who are under standard treatments or resistant to standard treatments with slight bone marrow suppressionJPRN-UMIN000019390Kurume University Cancer Vaccine Center1,000